Sleep Number Climbs 185% in 12 Weeks While Trading at 0.18x Sales
Sleep Number stock surged 57.8% over four weeks and 185.1% across 12 weeks, reflecting strong investor interest and a high beta of 1.89. Despite rapid gains, shares trade at just 0.18 times sales and benefit from upward earnings estimate revisions earning a Zacks Rank #2.
1. Recent Price Momentum
Sleep Number shares have gained 57.8% over the past four weeks and 185.1% over 12 weeks, underscoring heightened market interest in its beds and bedding products. The stock’s beta of 1.89 indicates it moves nearly twice as much as the broader market, reflecting significant volatility and upside potential.
2. Valuation and Analyst Outlook
At a price-to-sales ratio of just 0.18, Sleep Number trades cheaply relative to its revenue, suggesting attractive upside if momentum persists. Upward revisions to earnings estimates have secured a Zacks Rank #2 (Buy), signaling analysts’ confidence in its future profitability.